<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13D-102)
INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ALGOS PHARMACEUTICAL CORPORATION
(NAME OF ISSUER)
COMMON STOCK, PAR VALUE $.01 PER SHARE
(TITLE OF CLASS OF SECURITIES)
015869 10 0
(CUSIP NUMBER)
Page 1 of 5 pages
<PAGE>
<PAGE>
13G
CUSIP NO. 015869 10 0
-----------
1. NAME OF REPORTING PERSON:
Morris J. Kramer
----------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(A) [ ]
(B) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION:
United States citizen
-----------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
5. SOLE VOTING POWER:
809,246
---------------------------------------------------------
6. SHARED VOTING POWER:
-0-
---------------------------------------------------------
7. SOLE DISPOSITIVE POWER:
809,246
---------------------------------------------------------
8. SHARED DISPOSITIVE POWER:
-0-
---------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
809,246
---------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES:
[ ]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9:
5.2%
---------------------------------------------------------
12. TYPE OF REPORTING PERSON:
IN
---------------------------------------------------------
Page 2 of 5 pages
<PAGE>
<PAGE>
ITEM 1.
(a) Name of Issuer: Algos Pharmaceutical Corporation
(b) Address of Issuer's Principal Executive Offices:
Collingwood Plaza, 4900 Route 33
Neptune, New Jersey 07753-6804S
ITEM 2.
(a) Name of Person Filing: Morris J. Kramer
(b) Address of Principal Business Office:
Skadden, Arps et al LLP
919 Third Avenue
New York, New York 10022-3897
(c) Citizenship: United States
(d) Title of Class of Securities:
Common Stock, $.01 par value
(e) CUSIP Number: 015869 10 0
ITEM 3. Not applicable.
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned: 809,246
(b) Percent of Class: 5.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
809,246
---------------------------------------------
(ii) shared power to vote or to direct the vote:
-0-
---------------------------------------------
(iii) sole power to dispose or to direct the
disposition of:
809,246
---------------------------------------------
(iv) shared power to dispose or to direct the
disposition of:
-0-
---------------------------------------------
Page 3 of 5 pages
<PAGE>
<PAGE>
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON:
Of the shares reported by Mr. Kramer, 809,246 shares are held in
a trust for which Mr. Kramer holds the power of disposition and
the power to vote.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY:
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP:
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not applicable.
ITEM 10. CERTIFICATION:
Not applicable.
Page 4 of 5 pages
<PAGE>
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 20, 1997
\s\ Morris J. Kramer
---------------------------------------
Morris J. Kramer
Page 5 of 5 pages
